Recent Quotes

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products. The majority of the revenue is generated from the United States.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS		-0.090		-0.080		0.0100
REV		17.380M		15.473M		-1.907M

Q4 2020		Est.		Actual		Surprise
EPS		-0.080		-0.090		-0.0100
REV		15.660M		15.164M		-496.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
RMTI	Rockwell Medical	0.95	0.01	1.06%		88M

Rockwell Medical Frequently Asked Questions

How do I buy Rockwell Medical (RMTI) stock?

You can purchase shares of Rockwell Medical (NASDAQ: RMTI) through any online brokerage.

View our list of the best stock brokerages.

Who are Rockwell Medical's (RMTI) competitors?

Other companies in Rockwell Medical’s space includes: Chembio Diagnostics (NASDAQ:CEMI), TELA Bio (NASDAQ:TELA), Predictive Oncology (NASDAQ:POAI), InspireMD (NASDAQ:NSPR) and SI-BONE (NASDAQ:SIBN).

What is the target price for Rockwell Medical (RMTI) stock?

The latest price target for Rockwell Medical (NASDAQ: RMTI) was reported by HC Wainwright & Co. on February 8, 2021. The analyst firm set a price target for 5.50 expecting RMTI to rise to within 12 months (a possible 485.11% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Rockwell Medical (RMTI)?

The stock price for Rockwell Medical (NASDAQ: RMTI) is $0.94 last updated Today at 8:00:03 PM.

Does Rockwell Medical (RMTI) pay a dividend?

There are no upcoming dividends for Rockwell Medical.

When is Rockwell Medical (NASDAQ:RMTI) reporting earnings?

Rockwell Medical’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Rockwell Medical (RMTI) going to split?

There is no upcoming split for Rockwell Medical.

What sector and industry does Rockwell Medical (RMTI) operate in?

Rockwell Medical is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.